Ultragenyx Pharmaceutical Inc. buy melinda
Start price
05.01.17
/
50%
€68.19
Target price
27.02.17
€76.67
Performance (%)
12.65%
End price
27.02.17
€76.81
Summary
This prediction ended on 27.02.17 with a price of €76.81. The prediction had a final performance of 12.65%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 6.000% | 6.000% | 44.022% | -34.161% |
| iShares Core DAX® | 1.195% | 2.111% | 17.166% | 16.919% |
| iShares Nasdaq 100 | 3.220% | -1.375% | 22.801% | 33.740% |
| iShares Nikkei 225® | 1.858% | 0.888% | 10.064% | -0.682% |
| iShares S&P 500 | 2.168% | 0.612% | 22.739% | 38.274% |
Comments by melinda for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
folgen
$ RARE & Kyowa Kirin: MA für KRN23 eingereicht und zur Überprüfung durch den EMA akzeptiert. CHMP toh 2017 erwartet http: // ir.ultragenyx.com/releasedetail
Stopped prediction by melinda for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€73.50
25.08.20
25.08.20
€77.00
04.11.21
04.11.21
1.36%
05.11.21
05.11.21
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€50.68
31.08.17
31.08.17
€63.14
26.12.17
26.12.17
-14.69%
26.12.17
26.12.17
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€57.91
23.06.17
23.06.17
€76.67
20.07.17
20.07.17
8.44%
20.07.17
20.07.17
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€64.20
23.06.17
23.06.17
€85.00
20.07.17
20.07.17
8.44%
20.07.17
20.07.17